logo
Select company
Select metric
$ -797KNet Cash Flow - Issuance (Repayment) of Debt Securities
VS
Market
62
Sector
76
Industry
84
History
68
$ 1.01Close
$ 0.47 - $ 4.22 52-Week Range
Ticker Information

Ticker

NBY

Company Name

NOVABAY PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NOVABAY PHARMACEUTICALS INC - Net Cash Flow - Issuance (Repayment) of Debt Securities Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NBY - CF - Debt Historical data
DateNet Cash Flow - Issuance (Repayment) of Debt Securities
6/30/2025$ -797K
3/31/2025$ -1.51M
12/31/2024$ -1.6M
9/30/2024$ -2.7M
6/30/2024$ -2.48M
3/31/2024$ 748K
12/31/2023$ 1.34M
9/30/2023$ 1.94M
6/30/2023$ 2.51M
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NOVABAY PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Debt stands at $ -3.21M.
  • Over the past 5 years, NOVABAY PHARMACEUTICALS INC's average CF - Debt has been $ -537.4K.
  • The median CF - Debt for NOVABAY PHARMACEUTICALS INC during this period was $ -52.5K
  • NOVABAY PHARMACEUTICALS INC reached its highest CF - Debt over the past 5 years at $ 2.51M.
  • The lowest CF - Debt recorded by NOVABAY PHARMACEUTICALS INC in the same timeframe $ -3.21M

NOVABAY PHARMACEUTICALS INC's CF - Debt vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Debt Benchmarks
CompanyCF - Debt
INM : INMED PHARMACEUTICALS INC $ 0XBIO : XENETIC BIOSCIENCES INC $ 0CNSP : CNS PHARMACEUTICALS INC $ -299.04KENVB : ENVERIC BIOSCIENCES INC $ 0CPHI : CHINA PHARMA HOLDINGS INC $ -85.58KGRI : GRI BIO INC $ 0AZTR : AZITRA INC $ 679KONCO : ONCONETIX INC $ -2.67MSPRB : SPRUCE BIOSCIENCES INC $ -1.62MREVB : REVELATION BIOSCIENCES INC $ 0

Definition of Net Cash Flow - Issuance (Repayment) of Debt Securities

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.

NBY - Net Cash Flow - Issuance (Repayment) of Debt Securities, Last 5 years

$ -3.21M

Minimum

Sep 30, 2020

$ 2.51M

Maximum

Jun 30, 2023

$ -537.4K

Average

$ -52.5K

Median

CF - Debt Benchmark Analysis

The chart above depicts the distribution of CF - Debt for companies in the Total Stock Market. The average CF - Debt of the companies is $ -1.64M with a standard deviation of $ 24.12M.
The following table provides additional summary stats:
CF - Debt in the Market:
filtered constituents2.85K
min$ -84M
max$ 83.81M
average$ -1.64M
median$ 0
std$ 24.12M